Benzo`1,4 ! diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof

Details for Australian Patent Application No. 2004309173 (hide)

Owner NEURO3D

Inventors Wagner, Patrick; Duranton, Jerome; Limanton, Emmanuelle; Mondadori, Cesare; Biondi, Stefano; Abarghaz, Mustapha

Agent Davies Collison Cave

Pub. Number AU-A-2004309173

PCT Pub. Number WO2005/063723

Priority 03293309.5 23.12.03 EP

Filing date 23 December 2004

Wipo publication date 14 July 2005

International Classifications

C07D 243/24 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/063723 Priority application(s): WO2005/063723

19 June 2008 Assignment before Grant

  NEURO3D The application has been assigned to VIA Pharmaceuticals Inc.

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309177-A process for the preparation and purification of recombinant proteins

2004309171-Sugar and lipid metabolism regulators in plants VI